Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Post-Bariatric Hypoglycemia (LUCIDITY)

Lead Author: Ryan Miller, MD

Published: World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Date: December 12, 2024

Read more (opens new window)

Amylyx Update on Development of AMX0114, an Antisense Oligonucleotide Targeting Calpain-2

Lead Author: Lauren Kett, MD, PhD (Presenter)

Published: ALS ONE’s 7th Annual ALS Research Symposium

Date: November 14, 2024

Read more (opens new window)

Results from the HELIOS Trial: A Phase 2 Open-Label Study Evaluating an Oral, Fixed-Dose Combination of Sodium Phenylbutyrate and Taurursodiol in Wolfram Syndrome

Lead Author: Amy Viehoever, MD, PhD (Presenter)

Published: Child Neurology Society Annual Meeting

Date: November 11 - 14, 2024

Read more (opens new window)

A Phase 1, Multicenter, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AMX0114 in Amyotrophic Lateral Sclerosis (LUMINA)

Lead Author: Lauren Kett, MD, PhD (Presenter)

Published: Northeast ALS Consortium (NEALS) Annual Meeting

Date: October 23, 2024

Read more (opens new window)

Results from the Phase 2, Open-Label Study Evaluating an Oral, Fixed-Dose Combination of Sodium Phenylbutyrate and Taurursodiol (PB&TURSO) in Wolfram Syndrome

Lead Author: Nathalie Erpelding, PhD (Presenter)

Published: 9th International Wolfram Syndrome Symposium

Date: October 23, 2024

Read more (opens new window)

Results from A Phase 2, Open-Label Study Evaluating an Oral, Fixed-Dose Combination of Sodium Phenylbutyrate and Taurursodiol (PB&TURSO) in Wolfram Syndrome (HELIOS)

Lead Author: Lahar Mehta, MD (Presenter)

Published: International Society for Pediatric and Adolescent Diabetes (ISPAD) 50th Annual Congress

Date: October 17, 2024

Read more (opens new window)

ORION: A Global Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial of AMX0035 in Progressive Supranuclear Palsy (A35-009)

Lead Author: Anne-Marie Wills, MD

Published: International Parkinson and Movement Disorder Society

Date: October 1, 2024

Read more (opens new window)

Biological Effects of Sodium Phenylbutyrate and Taurursodiol in Alzheimer's Disease

Lead Author: Steven E. Arnold

Published: Alzheimer’s & Dementia: Translational Research & Clinical Interventions, a journal of the Alzheimer’s Association

Date: August 9, 2024

Read more (opens new window)

Preclinical Development of AMX0114, an Antisense Oligonucleotide Targeting Calpain-2

Lead Author: Evan Mizerak (Presenter)

Published: Oligonucleotides for CNS Summit

Date: July 10, 2024

Read more (opens new window)

Learnings from the CENTAUR and PHOENIX Trials: Biomarker Results

Lead Author: Sabrina Paganoni, MD, PhD (Presenter)

Published: European Network to Cure ALS (ENCALS) Meeting 2024

Date: June 17 - 20, 2024

Read more (opens new window)